In a study of 84 cases, Li et al., 201616 found that the enhancement texture from the first post-contrast MR images were highly correlated to the molecular subtypes of breast cancer (normal-like, luminal A and B, HER2-enriched, and basal-like). The gene discussed is ERBB2; the disease is breast carcinoma.